{"status":"ok","elements":"\n\n
\n \n\n\n
\n\n\t\t\t\t\t
\n \"\" <\/div>\n \n\t\t
\n Hitting the nerve of Crohn\u2019s disease: An update on our funding towards exploring alternative therapeutic avenues <\/div>\n \n\t\t
\n

An update on our current funded project of just over \u00a3130,000 over two years   We wanted to share an update on a research project we have funded to a group of investigators at the University of Oxford (Dr Khalid Shamiyah, Dr Matthias Friedrich, Dr Katharine Baker, Dr Bruce George, Dr Mathilde Pohin, Prof Fiona Powrie). Crohn\u2019s Disease (CD) is a chronic inflammatory bowel condition that significantly impacts quality of life, with most patients requiring surgery at some point. Recent discoveries suggest that the enteric nervous system (ENS) may hold critical insights into the disease\u2019s progression and potential new treatment…<\/p>\n <\/div>\n \n <\/div>\n\n<\/a>\n<\/div>\n\n

\n \n\n\n
\n\n\t\t\t\t\t \n\t\t
\n An update on two research projects funded by our \u00a360,000 donation <\/div>\n \n\t\t
\n

Project one Occtopus has funded two projects, totalling \u00a360,000, spearheaded by the renowned Simon Buczacki, a Professor in Colorectal Surgery who is based at Oxford University Hospitals and the University of Oxford. Professor Simon Buczacki The first was a one year project, which was completed in Spring 2023, and was run by University of Oxford Masters student Minn-E Ng. This was a laboratory based research project exploring the effect of tumour cell differentiation on colorectal cancer immunogenicity. In this study, the team focussed on a type of cell, called Paneth cells – named after the scientist who discovered them in…<\/p>\n <\/div>\n \n <\/div>\n\n<\/a>\n<\/div>\n\n

\n \n\n\n
\n\n\t\t\t\t\t
\n \"\" <\/div>\n \n\t\t
\n Our donation of \u00a3150,000 for the detection and treatment of pre-cancerous cells <\/div>\n \n\t\t
\n

We are proud to announce a substantial donation of \u00a3150,000 towards the establishment of a groundbreaking service for the detection of precancerous cells.\u00a0 The pioneering initiative, spearheaded by David James, Consultant Colorectal Surgeon at Oxford University Hospitals NHS Trust, aims to identify and treat precancerous cells before they progress to anal cancer.\u00a0\u00a0 In the UK, there are 1,500 new anal cancer cases each year, with the number of new cases projected to rise from around 1,900 cases in 2023-2025 to around 2,400 cases in 2038-20401. It particularly affects those who are immunosuppressed, for example transplant patients, and early detection is…<\/p>\n <\/div>\n \n <\/div>\n\n<\/a>\n<\/div>","max_pages":3}